The Centers for Disease Control and Prevention and Food and Drug Administration are investigating a multistate outbreak of salmonella linked to products reported to contain kratom, a plant consumed for its stimulant effects and as an opioid substitute. According to CDC, 28 people in 20 states have been infected since mid-October, 11 of whom were hospitalized. No common brands or suppliers of kratom have been identified. The agencies are advising consumers to avoid kratom and kratom-containing products. “In addition to the public health concerns raised by this outbreak, kratom affects the same opioid brain receptors as morphine and appears to have properties that expose people who consume kratom to the risks of addiction, abuse and dependence,” FDA said. In other news, FDA today announced the voluntary destruction and recall of kratom-containing dietary supplements made by Divinity Products Distribution. The agency is not aware of recent reports of illness associated with the Divinity products, but asks health care professionals to report any adverse events involving kratom products to its Safety Reporting Portal.
 

Related News Articles

Webinar Recordings
Member
Project SHOUT (Support for Hospital Opioid Use Treatment): Zuckerberg San Francisco General, San Francisco, CA Held N
Case Studies
Overview In May 2014, the Ohio Governor’s Office of Health Transformation awarded MetroHealth Medical Center in Cleveland $395,170 in gra
Case Studies
Overview Dartmouth–Hitchcock Medical Center (DHMC) is New Hampshire’s only academic medical center and is headquartered on a 225-acre cam
Webinar Recordings
Member
Held November 15 The Alliance for Recovery-Centered Addiction Health Services, of whic
Advisory
Member
This AHA Legislative Advisory offers a detailed summary of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for…
Webinar Recordings
Member
Members Only webinar presentation and discussion on Project SHOUT: Support for Hospital Opioid Use Treatment.